MAPT and Alzheimer disease: The lack of additive value for the tau markers over SPARE-AD is somewhat expected, as tau levels and brain atrophy tend to correlate well (Toledo et al., 2013b), and potentially MRI-derived SPARE-AD index more directly captures neurodegeneration.